Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis (Q49323238)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1985

Language	Label	Description	Also known as
English	Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis	scientific article published in January 1985

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

liver cirrhosis

0 references

1 reference

based on heuristic

inferred from title

primary biliary cholangitis

0 references

author name string

H P Hoensch

1

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

K Balzer

2

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

P Dylewizc

3

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

W Kirch

4

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

H Goebell

5

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

E E Ohnhaus

6

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

28

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

4

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

475-477

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenobarbital treatment in primary biliary cirrhosis. Differences in bile acid composition between responders and nonresponders

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple and sensitive assay of total serum bile acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenobarbital Effects in Cholestatic Liver Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rifampin on biliary lipids in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and pharmacokinetics of the antibiotic rifampin

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Pharmacokinetics of Rifampicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenobarbital-induced alterations of bile acid metabolism in cases of intrahepatic cholestasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme induction and renal function in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/4029252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00544371

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 February 2018

http://europepmc.org/abstract/MED/4029252

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49323238&oldid=2225203384"